Sales rise 11.27% to Rs 32.67 crore
Net loss of Jagsonpal Pharmaceuticals reported to Rs 1.23 crore in the quarter ended March 2018 as against net profit of Rs 0.82 crore during the previous quarter ended March 2017. Sales rose 11.27% to Rs 32.67 crore in the quarter ended March 2018 as against Rs 29.36 crore during the previous quarter ended March 2017.For the full year,net loss reported to Rs 11.55 crore in the year ended March 2018 as against net profit of Rs 11.86 crore during the previous year ended March 2017. Sales declined 12.05% to Rs 126.53 crore in the year ended March 2018 as against Rs 143.87 crore during the previous year ended March 2017.
ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales32.6729.36 11 126.53143.87 -12 OPM %-3.761.63 --8.784.27 - PBDT-1.150.33 PL -11.313.58 PL PBT-1.170.10 PL -11.631.59 PL NP-1.230.82 PL -11.5511.86 PL
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
